Product Information

GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0478 per EA under NDC 42571010305. Its NADAC has been published 287 times since Mar 19, 2014.

FDA first approved this application on Jun 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GLIMEPIRIDE 4 MG TABLET

Glimepiride
$0.0478per EA
High Outlier

Strength

4 mg/1

Manufacturer

Micro Labs Limited

NDC

42571010305

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GLIMEPIRIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA091220

FDA Approved

6/29/2012

TE Code

AB

On Market Since

6/13/2013

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 287 times since Mar 19, 2014, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0478 per EA
All-time high$0.2276 (Feb 10, 2016)
All-time low$0.0274 (May 22, 2024)
52-week high$0.0524
52-week low$0.0375
Median price$0.0514
Average price$0.0825
Largest weekly change+115.0% (Feb 18, 2015)
Weeks tracked287
Tracking sinceMar 19, 2014

Price History

1W

+3.1%

1M

-5.6%

3M

-7.0%

6M

-7.7%

1Y

+6.5%

3Y

+15.2%

5Y

-71.0%

All

-17.7%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Micro Labs Limited, is $0.0478 per EA (NDC 42571010305), effective Nov 18, 2026.

How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 17.7%. It has been tracked across 287 weekly CMS publications since Mar 19, 2014.

What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?

Since Mar 19, 2014, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.2276 (Feb 10, 2016), with a median of $0.0514 per EA.

Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 4 MG TABLET, is $0.0323 per EA — about 32% below GLIMEPIRIDE 4 MG TABLET.

Who manufactures GLIMEPIRIDE 4 MG TABLET?

GLIMEPIRIDE 4 MG TABLET (NDC 42571010305) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.